Tokyo, Aug. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062526) titled 'A study comparing the 90-day risk of cardiovascular events (hospitalization for myocardial infarction, heart failure, or stroke) after initiation of oral antivirals (nirmatrelvir/ritonavir, molnupiravir, or ensitrelvir) among older outpatients with COVID-19' on Aug. 9.
Study Type:
Observational
Primary Sponsor:
Institute - The University of Osaka, Graduate School of Medicine Faculty of Medicine
Condition:
Condition - COVID-19 (outpatient episodes in late-elderly adults). The outcome is cardiovascular events (hospitalization for acute myocardial infarction, heart failure, or stroke).
Classification by malignancy - ...